Nanotube-Laser Combo Selectively Targets Cancer Cells, Study Shows

Join Our Community of Science Lovers!


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


Carbon nanotubes--tiny straws of pure carbon--have many properties that make them attractive for applications as varied as nanoelectronics and nanofibers. Scientists are recruiting carbon nanotubes in the fight against cancer, too. A report published online this week by the Proceedings of the National Academy of Sciences suggests that when paired with a modified laser beam, the rods can act as tiny heaters to selectively destroy tumor cells.

When exposed to near-infrared light, carbon nanotubes quickly release excess energy as heat. Nadine Wong Shi Kam and her colleagues at Stanford University exploited this property to attack cancerous cells. "One of the longstanding problems in medicine is how to cure cancer without harming normal body tissue," notes study co-author Hongjie Dai. Cancer cells tend to be coated in folate receptors, whereas normal cells are not. Thus, to ensure that the carbon nanotubes were attracted only to diseased cells, the researchers coated them with folate molecules. The team then shined a flashlight-size near-infrared laser on aqueous solutions of both tumor and normal cells. Although harmless to regular cells, the light heated the nanotubes to 70 degrees Celsius within two minutes, killing the cancer cells they had invaded.

The researchers hope to refine the process for future use. "Folate is just an experimental model that we used," Dai says. "In reality there are more interesting ways we can do this. For example, we can attach an antibody to a carbon nanotube to target a particular type of cancer cell." To that end, Dai is currently investigating the possibility of using the technique on mice with lymphoma because lymphoma cells have well-defined surface receptors that can be targeted.

It’s Time to Stand Up for Science

If you enjoyed this article, I’d like to ask for your support. Scientific American has served as an advocate for science and industry for 180 years, and right now may be the most critical moment in that two-century history.

I’ve been a Scientific American subscriber since I was 12 years old, and it helped shape the way I look at the world. SciAm always educates and delights me, and inspires a sense of awe for our vast, beautiful universe. I hope it does that for you, too.

If you subscribe to Scientific American, you help ensure that our coverage is centered on meaningful research and discovery; that we have the resources to report on the decisions that threaten labs across the U.S.; and that we support both budding and working scientists at a time when the value of science itself too often goes unrecognized.

In return, you get essential news, captivating podcasts, brilliant infographics, can't-miss newsletters, must-watch videos, challenging games, and the science world's best writing and reporting. You can even gift someone a subscription.

There has never been a more important time for us to stand up and show why science matters. I hope you’ll support us in that mission.

Thank you,

David M. Ewalt, Editor in Chief, Scientific American

Subscribe